MedPath

Artery Therapeutics, Inc.

Artery Therapeutics, Inc. logo
🇺🇸United States
Ownership
Private
Established
2004-01-01
Employees
1
Market Cap
-
Website
https://www.arterytx.com

Safety and Pharmacokinetics of Single Ascending Doses and Multiple Ascending Doses of CS6253 in Healthy Volunteers

Early Phase 1
Completed
Conditions
Alzheimer's Disease
Interventions
Drug: Placebo
Drug: CS6253 Solution for Injection
First Posted Date
2023-07-28
Last Posted Date
2025-05-11
Lead Sponsor
Artery Therapeutics, Inc.
Target Recruit Count
66
Registration Number
NCT05965414
Locations
🇪🇸

La Paz University Hospital, Madrid, Spain

© Copyright 2025. All Rights Reserved by MedPath